Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    November 2022
  1. VLACHADIS N, Vrachnis N
    A Review of Sickle Cell Disease.
    JAMA. 2022;328:1979.
    PubMed    


  2. KAVANAGH PL, Fasipe T, Wun T
    A Review of Sickle Cell Disease-Reply.
    JAMA. 2022;328:1979-1980.
    PubMed    


  3. LARKIN HD
    Gene Therapy for Sickle Cell Disease, beta-Thalassemia Enters Regulatory Reviews.
    JAMA. 2022;328:1798.
    PubMed    


    October 2022
  4. KUEHN BM
    Children With Sickle Cell Anemia Not Receiving Recommended Care.
    JAMA. 2022;328:1583-1584.
    PubMed    


    September 2022
  5. RUBIN R
    New Gene Therapy for beta-Thalassemia.
    JAMA. 2022;328:1030.
    PubMed    


    August 2022
  6. SLOMSKI A
    Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
    JAMA. 2022;328:415.
    PubMed    


    July 2022
  7. KAVANAGH PL, Fasipe TA, Wun T
    Sickle Cell Disease: A Review.
    JAMA. 2022;328:57-68.
    PubMed     Abstract available


    June 2022
  8. OSHIMA T, Kinjo K, Kinjo M
    Chronic Abdominal Pain and Anemia in a 59-Year-Old Man.
    JAMA. 2022 Jun 24. pii: 2793812. doi: 10.1001/jama.2022.9194.
    PubMed    


    February 2022
  9. SLOMSKI A
    Oral Daprodustat Treats Anemia in Chronic Kidney Disease.
    JAMA. 2022;327:710.
    PubMed    


    October 2021
  10. ABOU BAKER NM, Davis AM
    Gastrointestinal Evaluation of Iron Deficiency Anemia.
    JAMA. 2021;326:1624-1625.
    PubMed    


    September 2021
  11. KENTER MJH, Cohen AF
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    JAMA. 2021;326:974-975.
    PubMed    


  12. GURKAN UA
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    JAMA. 2021;326:975.
    PubMed    


  13. CASELLA JF, Kronsberg SS, Gorney RT
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.
    JAMA. 2021;326:975-976.
    PubMed    


    July 2021
  14. ZHANG H, Kilaru AS, Meisel ZF, Bao Y, et al
    Prescription Drug Monitoring Program Mandates and Opioids Dispensed Following Emergency Department Encounters for Patients With Sickle Cell Disease or Cancer With Bone Metastasis.
    JAMA. 2021;326:274-276.
    PubMed    


    June 2021
  15. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    PubMed    


  16. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    PubMed    


    May 2021

  17. Foreign Letters: London.
    JAMA. 2021;325:1907.
    PubMed    


    April 2021
  18. ZYLKE J
    Poloxamer 188 for Sickle Cell Disease.
    JAMA. 2021;325:1524.
    PubMed    


  19. CASELLA JF, Barton BA, Kanter J, Black LV, et al
    Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    JAMA. 2021;325:1513-1523.
    PubMed     Abstract available


  20. EHRENREICH H, Neubauer AP, Miskowiak K
    Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years.
    JAMA. 2021;325:1470-1471.
    PubMed    


  21. NATALUCCI G, Bucher HU, Fauchere JC
    Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years-Reply.
    JAMA. 2021;325:1471-1472.
    PubMed    


    February 2021
  22. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    PubMed     Abstract available


    January 2021
  23. ABBASI J
    Promising Strategies for Sickle Cell Disease and beta-Thalassemia.
    JAMA. 2021;325:121.
    PubMed    


    December 2020
  24. NATALUCCI G, Latal B, Koller B, Ruegger C, et al
    Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
    JAMA. 2020;324:2324-2327.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: